Global Giants Like Pfizer In Better Position To Tackle Counterfeiting
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Drug companies are stepping up efforts to fight counterfeit products that are emerging around the world as potential profits grow and penalties, compared to those associated with dealing in illegal narcotics, are relatively low